Drug survival and the associated predictors in South Korean patients with rheumatoid arthritis receiving tacrolimus
Eun-Young Park, Seung-Geun Lee, Eun-Kyoung Park, Dong-Wan Koo, Ji-Heh Park, Geun-Tae Kim, Hee-Sang Tag, Hyun-Ok Kim, Young-Sun Suh
Korean J Intern Med. 2018;33(1):193-202.   Published online 2016 Apr 6     DOI: https://doi.org/10.3904/kjim.2015.385
Citations to this article as recorded by Crossref logo
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritis: a retrospective chart review analysis
Han-Na Lee, Yun-Kyung Kim, Geun-Tae Kim, Eunyoung Ahn, Min Wook So, Dong Hyun Sohn, Seung-Geun Lee
Rheumatology International.2019; 39(5): 859.     CrossRef
Manipulating the expression of SARP family regulator BulZ and its target gene product to increase tacrolimus production
Dongxu Ma, Cheng Wang, Hong Chen, Jianping Wen
Applied Microbiology and Biotechnology.2018; 102(11): 4887.     CrossRef
Efficacy and survival of golimumab with and without methotrexate in patients with psoriatic arthritis: A retrospective study from daily clinical practice
Kassem Sharif, Omer Gendelman, Pnina Langevitz, Tatiana Reitblat, Abdulla Watad, Yehuda Shoenfeld, Josef Azuri, Howard Amital, Nicola Luigi Bragazzi, Ora Shovman
Best Practice & Research Clinical Rheumatology.2018; 32(5): 692.     CrossRef
Neutropenia in the Elderly: A Rheumatology Perspective
Su-Ann Yeoh, Christine Fox, Richard Hull
Drugs & Aging.2016; 33(8): 585.     CrossRef